Joinn Laboratories China Co., a leading player in the pharmaceutical and biotechnology sectors, is headquartered in China (CN) and operates extensively across Asia and beyond. Founded in 2015, the company has rapidly established itself as a key provider of preclinical and clinical research services, catering to a diverse range of clients in the life sciences industry. Specialising in drug development, Joinn Laboratories offers unique services that encompass pharmacology, toxicology, and bioanalytical testing. Their commitment to quality and innovation has positioned them as a trusted partner for pharmaceutical companies seeking to advance their research and development efforts. With a strong focus on regulatory compliance and scientific excellence, Joinn Laboratories continues to achieve significant milestones, solidifying its reputation in the global market.
How does Joinn Laboratories China Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Joinn Laboratories China Co's score of 24 is lower than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Joinn Laboratories China Co reported total carbon emissions of approximately 33,568,810 kg CO2e, comprising 319,400 kg CO2e from Scope 1 and 33,249,410 kg CO2e from Scope 2 emissions. This marks an increase from 2022, where total emissions were about 32,515,920 kg CO2e, with Scope 1 emissions at 263,650 kg CO2e and Scope 2 emissions at 32,252,260 kg CO2e. In 2021, the company recorded total emissions of approximately 11,409,700 kg CO2e, with Scope 1 at 272,990 kg CO2e and Scope 2 at 11,136,710 kg CO2e. Joinn Laboratories has not set specific reduction targets or initiatives as part of its climate commitments, and there are no emissions data reported for Scope 3. The company’s emissions data is not cascaded from any parent organization, indicating that it operates independently in its reporting and climate strategies. Overall, Joinn Laboratories is focused on transparency in its emissions reporting, although it currently lacks defined reduction targets or commitments to industry-standard initiatives such as the Science Based Targets initiative (SBTi).
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 272,990 | 000,000 | 000,000 |
| Scope 2 | 11,136,710 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Joinn Laboratories China Co has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
